Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05605704 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Olive Leaf Extracts in the Control of Diabet

Study acronym: Dia-Athr
StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 3, 2025 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Mar 15, 2023 to Sep 15, 2025v5 Show 4 more changesShow less
    • Primary endpoint revised
    • Study completion date: Apr 15, 2023 to Dec 15, 2025
    • Interventions: atherolive (Drug) to Atherolive (Drug), Placebo Atherolive (Drug)
    • Secondary endpoints expanded, about 13 words
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v4
  3. Start date: Dec 26, 2022 to Jan 1, 2023v3
  4. Start date: Nov 15, 2022 to Dec 26, 2022v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will be carried out in 2 emergency departments (at the exit of the emergency room) and 2 external consultations (endocrinology of the CHU FB Monastir and diabetology consultation, Jemmal hospital). Patients over 18 years of age with: -Diabets
Trial Details
NCT Number NCT05605704
Lead Sponsor University of Monastir
Conditions
(from sponsor)		 Diabetes Mellitus, Type 2
Related terms Diabetes Mellitus, Diabetes Mellitus, Type 2
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov